ipamorelin peptide definition uses CJC-1295/Ipamorelin in Miami & Doral, FL: What to Expect Ipamorelin (10mg vials) - Peptide

Research has demonstrated sustained growth hormone release following administration: Enhanced binding affinity to GHRH receptors compared to native GHRH Increased resistance to dipeptidyl peptidase-IV enzymatic degradation Sustained elevation of plasma growth hormone concentrations for several hours post-administration Dose-dependent increases in both growth hormone and IGF-1 levels Studies have shown that CJC-1295 increases plasma growth hormone levels by 2- to 10-fold for up to 6 days, with IGF-1 levels remaining elevated for 9-11 days following a single dose in human subjects

Ipamorelin: Subcutaneous injection

Schlwicke Engstrm K, Strmberg U, Lundh T, Johansson I, Vessby B, Hallmans G, Skerfving S, Broberg K

This injectable peptide does not cause major increases in cortisol or prolactin or hunger which makes it suitable for those who seek results without adverse effects

Investigated for minimal impact on cortisol, prolactin, and aldosterone during GH release